Erratum: Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target (Journal of Clinical Endocrinology and Metabolism (2010) 95 (5338-5347) DOI:10.1210/jc.2010-1421)

Laura A. Marlow, Jaclyn D'Innocenzi, Yilin Zhang, Stephen D. Rohl, Simon J. Cooper, Thomas Sebo, Clive Grant, Bryan McIver, Jan Kasperbauer, J. Trad Wadsworth, John D. Casler, Pamela W. Kennedy, W Edward Jr. Highsmith, Orlo Clark, Dragana Milosevic, Brian Netzel, Kendall Cradic, Shilpi Arora, Christian Beaudry, Stefan K. GrebeMarc L. Silverberg, David O. Azorsa, Robert Christian Smallridge, John A III Copland

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)4213
Number of pages1
JournalJournal of Clinical Endocrinology and Metabolism
Volume98
Issue number10
DOIs
StatePublished - Oct 2013

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Marlow, L. A., D'Innocenzi, J., Zhang, Y., Rohl, S. D., Cooper, S. J., Sebo, T., Grant, C., McIver, B., Kasperbauer, J., Wadsworth, J. T., Casler, J. D., Kennedy, P. W., Highsmith, W. E. J., Clark, O., Milosevic, D., Netzel, B., Cradic, K., Arora, S., Beaudry, C., ... Copland, J. A. III. (2013). Erratum: Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target (Journal of Clinical Endocrinology and Metabolism (2010) 95 (5338-5347) DOI:10.1210/jc.2010-1421). Journal of Clinical Endocrinology and Metabolism, 98(10), 4213. https://doi.org/10.1210/jc.2013-3312